These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 9794741)
21. Effect of ursodeoxycholic acid on copper induced oxidation of low density lipoprotein. Geetha A; Surendran R Pharmazie; 2005 Aug; 60(8):609-13. PubMed ID: 16124405 [TBL] [Abstract][Full Text] [Related]
22. Miscellaneous non-inflammatory musculoskeletal conditions. Bartter's and Gitelman's diseases. Favero M; Calò LA; Schiavon F; Punzi L Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):637-48. PubMed ID: 22142744 [TBL] [Abstract][Full Text] [Related]
23. Ascorbic acid inhibits the increase in low-density lipoprotein (LDL) susceptibility to oxidation and the proportion of electronegative LDL induced by intense aerobic exercise. Sánchez-Quesada JL; Jorba O; Payés A; Otal C; Serra-Grima R; González-Sastre F; Ordóñez-Llanos J Coron Artery Dis; 1998; 9(5):249-55. PubMed ID: 9710684 [TBL] [Abstract][Full Text] [Related]
24. LDL of Taiwanese vegetarians are less oxidizable than those of omnivores. Lu SC; Wu WH; Lee CA; Chou HF; Lee HR; Huang PC J Nutr; 2000 Jun; 130(6):1591-6. PubMed ID: 10827215 [TBL] [Abstract][Full Text] [Related]
25. Oxidation of low-density lipoproteins: effect of antioxidant content, fatty acid composition and intrinsic phospholipase activity on susceptibility to metal ion-induced oxidation. Croft KD; Williams P; Dimmitt S; Abu-Amsha R; Beilin LJ Biochim Biophys Acta; 1995 Feb; 1254(3):250-6. PubMed ID: 7857965 [TBL] [Abstract][Full Text] [Related]
26. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling. Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089 [TBL] [Abstract][Full Text] [Related]
27. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration. Panzetta O; Cominacini L; Garbin U; Fratta Pasini A; Gammaro L; Bianco F; Davoli A; Campagnola M; De Santis A; Pastorino AM Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710 [TBL] [Abstract][Full Text] [Related]
28. Oxidation of low density lipoprotein in hemodialysis patients: effect of dialysis and comparison with matched controls. Westhuyzen J; Saltissi D; Healy H Atherosclerosis; 1997 Mar; 129(2):199-205. PubMed ID: 9105562 [TBL] [Abstract][Full Text] [Related]
29. Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid composition. Meyer DF; Nealis AS; Macphee CH; Groot PH; Suckling KE; Bruckdorfer KR; Perkins SJ Biochem J; 1996 Oct; 319 ( Pt 1)(Pt 1):217-27. PubMed ID: 8870672 [TBL] [Abstract][Full Text] [Related]
30. Long-chain n-3 polyunsaturated fatty acid from fish oil modulates aortic nitric oxide and tocopherol status in the rat. López D; Möller M; Denicola A; Casós K; Rubbo H; Ruiz-Sanz JI; Mitjavila MT Br J Nutr; 2008 Oct; 100(4):767-75. PubMed ID: 18341754 [TBL] [Abstract][Full Text] [Related]
31. Bartter's and Gitelman's syndromes: from gene to clinic. Naesens M; Steels P; Verberckmoes R; Vanrenterghem Y; Kuypers D Nephron Physiol; 2004; 96(3):p65-78. PubMed ID: 15056980 [TBL] [Abstract][Full Text] [Related]
32. Effects of Ca-antagonists on oxidative susceptibility of low density lipoprotein (LDL). Yoshida H; Ayaori M; Suzukawa M; Hosoai H; Nishiwaki M; Ishikawa T; Nakamura H Hypertens Res; 1995 Mar; 18(1):47-53. PubMed ID: 7584910 [TBL] [Abstract][Full Text] [Related]
33. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients. Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163 [TBL] [Abstract][Full Text] [Related]
34. Different mechanisms are progressively recruited to promote Cu(II) reduction by isolated human low-density lipoprotein undergoing oxidation. Perugini C; Seccia M; Bagnati M; Cau C; Albano E; Bellomo G Free Radic Biol Med; 1998 Sep; 25(4-5):519-28. PubMed ID: 9741588 [TBL] [Abstract][Full Text] [Related]
35. n-3 fatty acid incorporation into LDL particles renders them more susceptible to oxidation in vitro but not necessarily more atherogenic in vivo. Whitman SC; Fish JR; Rand ML; Rogers KA Arterioscler Thromb; 1994 Jul; 14(7):1170-6. PubMed ID: 8018674 [TBL] [Abstract][Full Text] [Related]
36. Increased low-density lipoprotein peroxidation in elderly men. Napoli C; Abete P; Corso G; Malorni A; Postiglione A; Ambrosio G; Cacciatore F; Rengo F; Palumbo G Coron Artery Dis; 1997; 8(3-4):129-36. PubMed ID: 9237021 [TBL] [Abstract][Full Text] [Related]
37. [The Gitelman syndrome--a differential diagnosis of Bartter syndrome]. Zimmermann J; Reincke M; Schramm L; Harlos J; Allolio B Med Klin (Munich); 1994 Dec; 89(12):640-4. PubMed ID: 7869998 [TBL] [Abstract][Full Text] [Related]
38. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Ishikawa T; Suzukawa M; Ito T; Yoshida H; Ayaori M; Nishiwaki M; Yonemura A; Hara Y; Nakamura H Am J Clin Nutr; 1997 Aug; 66(2):261-6. PubMed ID: 9250103 [TBL] [Abstract][Full Text] [Related]
39. Plasma thiols inhibit hemin-dependent oxidation of human low-density lipoprotein. Lynch SM; Campione AL; Moore MK Biochim Biophys Acta; 2000 May; 1485(1):11-22. PubMed ID: 10802245 [TBL] [Abstract][Full Text] [Related]
40. Properties of low density lipoproteins relevant to oxidative modifications change paradoxically during aging. Stulnig TM; Jürgens G; Chen Q; Moll D; Schönitzer D; Jarosch E; Wick G Atherosclerosis; 1996 Sep; 126(1):85-94. PubMed ID: 8879437 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]